Narula Surgicals Pvt Ltd - Due diligence report

A 360° intelligence report on Narula Surgicals Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distre…

1997-06-09 New Delhi, Delhi Active Unlisted Active Compliant
Share
NS Narula Surgicals Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Narula Surgicals Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Narula Surgicals Pvt Ltd is assessed as Low Risk with a Trust Score of 88/100. Narula Surgicals Pvt Ltd is an active private limited indian non-government company incorporated in 1997, operating in the Home & Lifestyle sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Narula Surgicals Pvt Ltd snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
YOGESH KUMAR JAIN 01234567 Director 01/04/2018 6 yrs Approved
NEENA JAIN 01234567 Director 01/04/2018 6 yrs Approved
NARESH KHURANA 01234567 Director 01/04/2018 6 yrs Approved
Rajiv Jain 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 29+ years.
Distress signals & risk flags
Outside liabilities up 24% in a year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment83/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
29 Sep 2025
Director ceased
NARESH KHURANA
Director ceased
Rajiv Jain
28 Apr 2025
Director appointed
NARESH KHURANA (Director)
Director appointed
Rajiv Jain (Director)
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
30 Mar 2014
Securities allotted
68000.00 Equity Shares - 6.80 Lakh raised
14 Feb 2013
Director ceased
SEEMA JAIN
11 Feb 2013
Director appointed
NEENA JAIN (Director)
06 May 2008
Director ceased
RAJENDER PARTAP NARULA
Director ceased
SURENDER PRATAP NARULA
Director ceased
VISHAL NARULA
20 Mar 2008
Director appointed
YOGESH KUMAR JAIN (Director)
09 Jun 1997
Incorporated
Registered with Roc Delhi
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Manohar Tradelinks Private Limited U51109WB2007PTC113617 Kolkata, West Bengal, India
Cysum Pharmaceuticals Private Limited U74999UP2017PTC096145 Noida, Uttar Pradesh, India
Chopra Garments Private Ltd U74899DL1986PTC024326 New Delhi, Delhi, India
Kryptar India Private Limited U70109UP2017PTC096038 Ghaziabad, Uttar Pradesh, India
Antilia Heights Private Limited U70200DL2010PTC203046 New Delhi, Delhi, India
Megacity Landcon Private Limited U41001WB2011PTC164280 Kolkata, West Bengal, India
Sooryam Medi And Healthcare Private Limited U85100DL2021PTC383139 Delhi, Delhi, India
Katha U18109MH2013PTC247169 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Narula Surgicals Pvt Ltd before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Narula Surgicals Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Narula Surgicals Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Narula Surgicals Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Narula Surgicals Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Narula Surgicals Pvt Ltd an active company?

Narula Surgicals Pvt Ltd has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Narula Surgicals Pvt Ltd financially healthy?

Narula Surgicals Pvt Ltd has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Narula Surgicals Pvt Ltd?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Narula Surgicals Pvt Ltd?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Narula Surgicals Pvt Ltd have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Narula Surgicals Pvt Ltd up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Narula Surgicals Pvt Ltd?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.